CRTE7A2-01 TCR-T Cell for HPV-16 Positive Advanced Cervical, Anal, or Head and Neck Cancers
Clinical trial NCT05122221 · UNKNOWN
Trial details
- NCT number
- NCT05122221
- Sponsor
- Corregene Biotechnology Co., Ltd
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-17
- Primary completion
- 2023-03-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.